Oscar Health Inc (OSCR) concluded trading on Wednesday at a closing price of $13.76, with 4.19 million shares of worth about $57.67 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.47% during that period and on February 12, 2025 the price saw a loss of about -2.48%. Currently the company’s common shares owned by public are about 214.97M shares, out of which, 173.80M shares are available for trading.
Stock saw a price change of -12.63% in past 5 days and over the past one month there was a price change of -2.89%. Year-to-date (YTD), OSCR shares are showing a performance of 2.38% which decreased to -22.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.05 but also hit the highest price of $23.79 during that period. The average intraday trading volume for Oscar Health Inc shares is 4.16 million. The stock is currently trading -12.43% below its 20-day simple moving average (SMA20), while that difference is down -9.02% for SMA50 and it goes to -20.89% lower than SMA200.
Oscar Health Inc (NYSE: OSCR) currently have 214.97M outstanding shares and institutions hold larger chunk of about 63.94% of that.
The stock has a current market capitalization of $3.40B and its 3Y-monthly beta is at 1.74. It has posted earnings per share of -$0.02 in the same period. It has a debt-to-equity ratio of 0.30. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OSCR, volatility over the week remained 6.79% while standing at 6.63% over the month.
Stock’s fiscal year EPS is expected to rise by 647.59% while it is estimated to increase by 39.22% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on December 10, 2024 offering an Underperform rating for the stock and assigned a target price of $12 to it. Coverage by BofA Securities stated Oscar Health Inc (OSCR) stock as an Underperform in their note to investors on November 06, 2024, suggesting a price target of $13.50 for the stock. On October 07, 2024, UBS Initiated their recommendations, while on June 26, 2024, Piper Sandler Initiated their ratings for the stock with a price target of $25. Stock get an Outperform rating from Robert W. Baird on May 30, 2024.
